3D-printed scaffold of dopamine methacrylate oligomer grafted on PEGDMA incorporated with collagen hydrolysate for engineering cartilage tissue
2
Issued Date
2024-01-01
Resource Type
eISSN
24248002
Scopus ID
2-s2.0-85214313263
Journal Title
International Journal of Bioprinting
Volume
10
Issue
6
Start Page
338
End Page
359
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Bioprinting Vol.10 No.6 (2024) , 338-359
Suggested Citation
Pasanaphong K., Suksuwan A., Srikaew N., Hemstapat R., Tawonsawatruk T., Wangtueai S., Khamthong N., Boonyagul S., Wongsirichot P., Tanadchangsaeng N. 3D-printed scaffold of dopamine methacrylate oligomer grafted on PEGDMA incorporated with collagen hydrolysate for engineering cartilage tissue. International Journal of Bioprinting Vol.10 No.6 (2024) , 338-359. 359. doi:10.36922/ijb.4385 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/102676
Title
3D-printed scaffold of dopamine methacrylate oligomer grafted on PEGDMA incorporated with collagen hydrolysate for engineering cartilage tissue
Corresponding Author(s)
Other Contributor(s)
Abstract
This study demonstrated the synthesis and characterization of dopamine methacrylate (DMA), oligomers of dopamine methacrylate (ODMA), and their integration with polyethylene glycol dimethacrylate (PEGDMA) to enhance 3D-printing scaffold fabrication for tissue engineering, using digital light processing (DLP) technology. The results confirm the successful synthesis of DMA, as evidenced by nuclear magnetic resonance (NMR) and Fourier transform infrared spectroscopy (FTIR) analysis and its subsequent conversion to ODMA. The obtained ODMA was then combined with PEGDMA (1.25–10% w/v ODMA) to optimize scaffold printability. The morphological characteristics of the ODMA/PEGDMA scaffolds were assessed via scanning electron microscopy (SEM). Furthermore, using FTIR and differential scanning calorimetry (DSC), the chemical stability and biological compatibility of collagen hydrolysate (CH) derived from tuna tendon were studied and compared after sterilization. An in vitro fibroblast viability test was conducted using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay to assess the biocompatibility of CH with cells. Sterilization did not adversely affect the chemical composition of CH, maintaining its compatibility with fibroblast cells. Subsequently, ODMA/PEGDMA/CH composite scaffolds were fabricated using a DLP 3D printer, and their efficacy in supporting chondrocyte viability and proliferation were examined at 24, 48, and 72 h using PrestoBlue® assay. Mixing ODMA with PEGDMA significantly enhanced the printability of the scaffolds. Our tri-component 3D-printed scaffolds significantly enhanced human cartilage stem/progenitor cell (CSPC) viability and proliferation compared to a 24-well culture plate. These scaffolds excel in both mechanical properties, crucial for bearing physiological loads, and biological properties that promote cell growth and proliferation. This dual enhancement underscores their superior performance and positions them as frontrunners in the development of advanced solutions for cartilage engineering, potentially revolutionizing medical treatments.